www.calicolabs.com
Calico Life Sciences Announces U.S. FDA Orphan Drug Designation for Investigational Treatment of Autosomal Dominant Polycystic Kidney Disease - Calico
South San Francisco, Calif., November 5, 2025 – Calico Life Sciences LLC (Calico), a biotechnology organization focused on aging and age-related diseases and ...
Leggi l'articolo su www.calicolabs.com